Cite

HARVARD Citation

    Becker, R. et al. (2012). The cost offsets and cost–effectiveness associated with pegylated drugs: a review of the literature. Expert review of pharmacoeconomics & outcomes research. pp. 775-793. [Online]. 
  
Back to record